Skip to main content

Table 1 Major eligibility criteria

From: Study protocol: watchful observation of patients with limited small cell lung cancer instead of the PCI—prospective, multi-center one-arm study

Inclusion criteria

Exclusion criteria

Diagnosis of LD-SCLC

Lack of signed informed consent of the patient

A radical treatment (chemoradiotherapy according to current clinical guidelines) with remission or good/very good response to treatment

Disseminated neoplastic disease

Good general condition of the patient (ECOG/WHO − 0-2)

Contraindications for cerebral MRI examination

MRI of the brain in staging before chemoradiation treatment

The patient is not able to perform tests assessing cognitive functions

Signed informed consent

Poor performance status (ECOG/WHO > 2)